Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Ультразвуковые исследования с контрастированием: история, применение в практике и перспективы - Журнал Терапевтический архив №4 Вопросы диагностики внутренних болезней 2023
Ультразвуковые исследования с контрастированием: история, применение в практике и перспективы
Миронова О.Ю., Исайкина М.А., Исаев Г.О., Бердышева М.В., Фомин В.В. Ультразвуковые исследования с контрастированием: история, применение в практике и перспективы. Терапевтический архив. 2023;95(4):354–358. DOI: 10.26442/00403660.2023.04.202157
© ООО «КОНСИЛИУМ МЕДИКУМ», 2023 г.
DOI: 10.26442/00403660.2023.04.202157
© ООО «КОНСИЛИУМ МЕДИКУМ», 2023 г.
________________________________________________
DOI: 10.26442/00403660.2023.04.202157
Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Аннотация
В статье обсуждаются этапы становления и развития ультразвуковой диагностики, в том числе с контрастным усилением. Изложены основные принципы усиления, виды контрастных препаратов. Приведены примеры использования контрастно-усиленного ультразвукового исследования в разных областях медицины. Обсуждены перспективы метода и его место в клинической практике.
Ключевые слова: история медицины, ультразвуковое исследование, ультразвуковое исследование с контрастным усилением, эхокардиография, контрастные препараты
Keywords: medical history, ultrasound, contrast-enhanced ultrasound, echocardiography, contrast agents
Ключевые слова: история медицины, ультразвуковое исследование, ультразвуковое исследование с контрастным усилением, эхокардиография, контрастные препараты
________________________________________________
Keywords: medical history, ultrasound, contrast-enhanced ultrasound, echocardiography, contrast agents
Полный текст
Список литературы
1. Wiener WR, Lausen GD. Audition for the Traveler Who Is Visually Impaired. In: Eds. BB Blasch, WR Wiener, RL Welsch. Foundations of Orientation and Mobility. New York: AFB Press, 1997; p. 146.
2. Marinesco N, Trillat JJ. Action des ultrasons sur les plaques photographique. C R Acad Sci. 1933;196:858-60.
3. Marinesco N. Propriétés piézo-chimiques, physiques et biophysiques des ultrasons. I et II. Actualités scientifiques et industrielles. 522 & 523. Paris: Hermann, 1937.
4. Dussik K. Über die Möglichkeit hochfrequente mechanische Schwingungen als diagnostiches Hilfsmittel zi verwenden. Z Neur. 1942;174:153.
5. Dussik K. Ultraschallanwendung in der Diagnostik und Therapie des Erkrankungen des zentralen Nervensus-sytems. Ultrasch in der Med. 1949;1:283.
6. Howry DH, Bliss WR. Ultrasonic visualization of soft tissue structures of the body. J Lab Clin Med. 1952;40:579-92.
7. Strandness DE Jr., McCutcheon EP, Rushmer RF. Application of a transcutaneous Doppler flowmeter in evaluation of occlusive arterial disease. Surg Gynecol Obstet. 1966;122(5):1039-45.
8. Leksell L. Echoencephalography I. Detection of intracranial complications following head injury. Acta Chir Scandinav. 1955;110:301.
9. Edler I, Hertz CH. The use of ultrasonic reflectoscope for the continuous recording of movements of heart walls. Kungl Fysiogr Sällsk i Lund firhandl. 1954;24:5.
10. Satomura S. Ultrasonic Doppler Method for the Inspection of Cardiac Functions. J Acoust Soc Am. 1957;29(11):1181-5. DOI:10.1121/1.1908737
11. Kasai C, Namekawa K, Koyano A, Omoto R. Real-Time Two-Dimensional Blood Flow Imaging Using an Autocorrelation Technique. IEEE Transactions on Sonics and Ultrasonics. 1985;32(3):458-64. DOI:10.1109/T-SU.1985.31615
12. Gramiak R, Shah P. Echocardiography of the aortic root. Invest Radiol. 1968;3:356-66.
13. Enhancing the Role of Ultrasound with Contrast Agents. Ed. R Lencioni. Springer, 2006; p. 262.
14. Feinstein SB, Shah PM, Bing RJ, et al. Microbubble dynamics visualized in the intact capillary circulation. J Am Coll Cardiol. 1984;4(3):595-600. DOI:10.1016/s0735-1097(84)80107-2
15. Schürmann R, Schlief R. Saccharide-based contrast agents. Characteristics and diagnostic potential. Radiol Med. 1994;87(5 Suppl. 1):15-23.
16. Kalantarinia K, Okusa MD. Ultrasound contrast agents in the study of kidney function in health and disease. Drug Discov Today Dis Mech. 2007;4(3):153-8. DOI:10.1016/j.ddmec.2007.10.006
17. Qin S, Caskey CF, Ferrara KW. Ultrasound contrast microbubbles in imaging and therapy: physical principles and engineering. Phys Med Biol. 2009;54(6):R27-57.
DOI:10.1088/0031-9155/54/6/R01
18. Wei K, Mulvagh SL, Carson L, et al. The safety of deFinity and Optison for ultrasound image enhancement: a retrospective analysis of 78,383 administered contrast doses. J Am Soc Echocardiogr. 2008;21(11):1202-6. DOI:10.1016/j.echo.2008.07.019
19. Lindner JR. Contrast echocardiography: current status and future directions. Heart. 2021;107(1):18-24. DOI:10.1136/heartjnl-2020-316662
20. Porter TR, Mulvagh SL, Abdelmoneim SS, et al. Clinical Applications of Ultrasonic Enhancing Agents in Echocardiography: 2018 American Society of Echocardiography Guidelines Update. J Am Soc Echocardiogr. 2018;31(3):241-74. DOI:10.1016/j.echo.2017.11.013
21. Levey AS, Cattran D, Friedman A, et al. Proteinuria as a surrogate outcome in CKD: report of a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration. Am J Kidney Dis. 2009;54(2):205-26. DOI:10.1053/j.ajkd.2009.04.029
22. Jeong S, Park SB, Kim SH, et al. Clinical significance of contrast-enhanced ultrasound in chronic kidney disease: a pilot study. J Ultrasound. 2019;22(4):453-60.
DOI:10.1007/s40477-019-00409-x
23. Wang L, Xia P, Lv K, et al. Assessment of renal tissue elasticity by acoustic radiation force impulse quantification with histopathological correlation: preliminary experience in chronic kidney disease. Eur Radiol. 2014;24(7):1694-9. DOI:10.1007/s00330-014-3162-5
24. Claudon M, Dietrich CF, Choi BI, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver – update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultraschall Med. 2013;34(1):11-29. DOI:10.1055/s-0032-1325499
25. Erlichman DB, Weiss A, Koenigsberg M, Stein MW. Contrast enhanced ultrasound: A review of radiology applications. Clin Imaging. 2020;60(2):209-15. DOI:10.1016/j.clinimag.2019.12.013
26. Bansal M, Kasliwal RR. Echocardiography for left atrial appendage structure and function. Indian Heart J. 2012;64(5):469-75. DOI:10.1016/j.ihj.2012.07.020
27. Eriksson MJ, Sonnenberg B, Woo A, et al. Long-term outcome in patients with apical hypertrophic cardiomyopathy. J Am Coll Cardiol. 2002;39(4):638-45.
DOI:10.1016/s0735-1097(01)01778-8
28. Hoffmann R, Barletta G, von Bardeleben S, et al. Analysis of left ventricular volumes and function: a multicenter comparison of cardiac magnetic resonance imaging, cine ventriculography, and unenhanced and contrast-enhanced two-dimensional and three-dimensional echocardiography. J Am Soc Echocardiogr. 2014;27(3):292-301. DOI:10.1016/j.echo.2013.12.005
29. Kurt M, Shaikh KA, Peterson L, et al. Impact of contrast echocardiography on evaluation of ventricular function and clinical management in a large prospective cohort. J Am Coll Cardiol. 2009;53(9):802-10. DOI:10.1016/j.jacc.2009.01.005
30. Ogbogu PU, Rosing DR, Horne MK 3rd. Cardiovascular manifestations of hypereosinophilic syndromes. Immunol Allergy Clin North Am. 2007;27(3):457-75. DOI:10.1016/j.iac.2007.07.001
31. Vos HJ, Voorneveld JD, Groot Jebbink E, et al. Contrast-Enhanced High-Frame-Rate Ultrasound Imaging of Flow Patterns in Cardiac Chambers and Deep Vessels. Ultrasound Med Biol. 2020;46(11):2875-90. DOI:10.1016/j.ultrasmedbio.2020.07.022
32. Frinking P, Segers T, Luan Y, Tranquart F. Three Decades of Ultrasound Contrast Agents: A Review of the Past, Present and Future Improvements. Ultrasound Med Biol. 2020;46(4):892-908. DOI:10.1016/j.ultrasmedbio.2019.12.008
33. Nittayacharn P, Yuan HX, Hernandez C, et al. Enhancing Tumor Drug Distribution With Ultrasound-Triggered Nanobubbles. J Pharm Sci. 2019;108(9):3091-8. DOI:10.1016/j.xphs.2019.05.004
34. Chong WK, Papadopoulou V, Dayton PA. Imaging with ultrasound contrast agents: current status and future. Abdom Radiol (NY). 2018;43(4):762-72.
DOI:10.1007/s00261-018-1516-1
2. Marinesco N, Trillat JJ. Action des ultrasons sur les plaques photographique. C R Acad Sci. 1933;196:858-60.
3. Marinesco N. Propriétés piézo-chimiques, physiques et biophysiques des ultrasons. I et II. Actualités scientifiques et industrielles. 522 & 523. Paris: Hermann, 1937.
4. Dussik K. Über die Möglichkeit hochfrequente mechanische Schwingungen als diagnostiches Hilfsmittel zi verwenden. Z Neur. 1942;174:153.
5. Dussik K. Ultraschallanwendung in der Diagnostik und Therapie des Erkrankungen des zentralen Nervensus-sytems. Ultrasch in der Med. 1949;1:283.
6. Howry DH, Bliss WR. Ultrasonic visualization of soft tissue structures of the body. J Lab Clin Med. 1952;40:579-92.
7. Strandness DE Jr., McCutcheon EP, Rushmer RF. Application of a transcutaneous Doppler flowmeter in evaluation of occlusive arterial disease. Surg Gynecol Obstet. 1966;122(5):1039-45.
8. Leksell L. Echoencephalography I. Detection of intracranial complications following head injury. Acta Chir Scandinav. 1955;110:301.
9. Edler I, Hertz CH. The use of ultrasonic reflectoscope for the continuous recording of movements of heart walls. Kungl Fysiogr Sällsk i Lund firhandl. 1954;24:5.
10. Satomura S. Ultrasonic Doppler Method for the Inspection of Cardiac Functions. J Acoust Soc Am. 1957;29(11):1181-5. DOI:10.1121/1.1908737
11. Kasai C, Namekawa K, Koyano A, Omoto R. Real-Time Two-Dimensional Blood Flow Imaging Using an Autocorrelation Technique. IEEE Transactions on Sonics and Ultrasonics. 1985;32(3):458-64. DOI:10.1109/T-SU.1985.31615
12. Gramiak R, Shah P. Echocardiography of the aortic root. Invest Radiol. 1968;3:356-66.
13. Enhancing the Role of Ultrasound with Contrast Agents. Ed. R Lencioni. Springer, 2006; p. 262.
14. Feinstein SB, Shah PM, Bing RJ, et al. Microbubble dynamics visualized in the intact capillary circulation. J Am Coll Cardiol. 1984;4(3):595-600. DOI:10.1016/s0735-1097(84)80107-2
15. Schürmann R, Schlief R. Saccharide-based contrast agents. Characteristics and diagnostic potential. Radiol Med. 1994;87(5 Suppl. 1):15-23.
16. Kalantarinia K, Okusa MD. Ultrasound contrast agents in the study of kidney function in health and disease. Drug Discov Today Dis Mech. 2007;4(3):153-8. DOI:10.1016/j.ddmec.2007.10.006
17. Qin S, Caskey CF, Ferrara KW. Ultrasound contrast microbubbles in imaging and therapy: physical principles and engineering. Phys Med Biol. 2009;54(6):R27-57.
DOI:10.1088/0031-9155/54/6/R01
18. Wei K, Mulvagh SL, Carson L, et al. The safety of deFinity and Optison for ultrasound image enhancement: a retrospective analysis of 78,383 administered contrast doses. J Am Soc Echocardiogr. 2008;21(11):1202-6. DOI:10.1016/j.echo.2008.07.019
19. Lindner JR. Contrast echocardiography: current status and future directions. Heart. 2021;107(1):18-24. DOI:10.1136/heartjnl-2020-316662
20. Porter TR, Mulvagh SL, Abdelmoneim SS, et al. Clinical Applications of Ultrasonic Enhancing Agents in Echocardiography: 2018 American Society of Echocardiography Guidelines Update. J Am Soc Echocardiogr. 2018;31(3):241-74. DOI:10.1016/j.echo.2017.11.013
21. Levey AS, Cattran D, Friedman A, et al. Proteinuria as a surrogate outcome in CKD: report of a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration. Am J Kidney Dis. 2009;54(2):205-26. DOI:10.1053/j.ajkd.2009.04.029
22. Jeong S, Park SB, Kim SH, et al. Clinical significance of contrast-enhanced ultrasound in chronic kidney disease: a pilot study. J Ultrasound. 2019;22(4):453-60.
DOI:10.1007/s40477-019-00409-x
23. Wang L, Xia P, Lv K, et al. Assessment of renal tissue elasticity by acoustic radiation force impulse quantification with histopathological correlation: preliminary experience in chronic kidney disease. Eur Radiol. 2014;24(7):1694-9. DOI:10.1007/s00330-014-3162-5
24. Claudon M, Dietrich CF, Choi BI, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver – update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultraschall Med. 2013;34(1):11-29. DOI:10.1055/s-0032-1325499
25. Erlichman DB, Weiss A, Koenigsberg M, Stein MW. Contrast enhanced ultrasound: A review of radiology applications. Clin Imaging. 2020;60(2):209-15. DOI:10.1016/j.clinimag.2019.12.013
26. Bansal M, Kasliwal RR. Echocardiography for left atrial appendage structure and function. Indian Heart J. 2012;64(5):469-75. DOI:10.1016/j.ihj.2012.07.020
27. Eriksson MJ, Sonnenberg B, Woo A, et al. Long-term outcome in patients with apical hypertrophic cardiomyopathy. J Am Coll Cardiol. 2002;39(4):638-45.
DOI:10.1016/s0735-1097(01)01778-8
28. Hoffmann R, Barletta G, von Bardeleben S, et al. Analysis of left ventricular volumes and function: a multicenter comparison of cardiac magnetic resonance imaging, cine ventriculography, and unenhanced and contrast-enhanced two-dimensional and three-dimensional echocardiography. J Am Soc Echocardiogr. 2014;27(3):292-301. DOI:10.1016/j.echo.2013.12.005
29. Kurt M, Shaikh KA, Peterson L, et al. Impact of contrast echocardiography on evaluation of ventricular function and clinical management in a large prospective cohort. J Am Coll Cardiol. 2009;53(9):802-10. DOI:10.1016/j.jacc.2009.01.005
30. Ogbogu PU, Rosing DR, Horne MK 3rd. Cardiovascular manifestations of hypereosinophilic syndromes. Immunol Allergy Clin North Am. 2007;27(3):457-75. DOI:10.1016/j.iac.2007.07.001
31. Vos HJ, Voorneveld JD, Groot Jebbink E, et al. Contrast-Enhanced High-Frame-Rate Ultrasound Imaging of Flow Patterns in Cardiac Chambers and Deep Vessels. Ultrasound Med Biol. 2020;46(11):2875-90. DOI:10.1016/j.ultrasmedbio.2020.07.022
32. Frinking P, Segers T, Luan Y, Tranquart F. Three Decades of Ultrasound Contrast Agents: A Review of the Past, Present and Future Improvements. Ultrasound Med Biol. 2020;46(4):892-908. DOI:10.1016/j.ultrasmedbio.2019.12.008
33. Nittayacharn P, Yuan HX, Hernandez C, et al. Enhancing Tumor Drug Distribution With Ultrasound-Triggered Nanobubbles. J Pharm Sci. 2019;108(9):3091-8. DOI:10.1016/j.xphs.2019.05.004
34. Chong WK, Papadopoulou V, Dayton PA. Imaging with ultrasound contrast agents: current status and future. Abdom Radiol (NY). 2018;43(4):762-72.
DOI:10.1007/s00261-018-1516-1
2. Marinesco N, Trillat JJ. Action des ultrasons sur les plaques photographique. C R Acad Sci. 1933;196:858-60.
3. Marinesco N. Propriétés piézo-chimiques, physiques et biophysiques des ultrasons. I et II. Actualités scientifiques et industrielles. 522 & 523. Paris: Hermann, 1937.
4. Dussik K. Über die Möglichkeit hochfrequente mechanische Schwingungen als diagnostiches Hilfsmittel zi verwenden. Z Neur. 1942;174:153.
5. Dussik K. Ultraschallanwendung in der Diagnostik und Therapie des Erkrankungen des zentralen Nervensus-sytems. Ultrasch in der Med. 1949;1:283.
6. Howry DH, Bliss WR. Ultrasonic visualization of soft tissue structures of the body. J Lab Clin Med. 1952;40:579-92.
7. Strandness DE Jr., McCutcheon EP, Rushmer RF. Application of a transcutaneous Doppler flowmeter in evaluation of occlusive arterial disease. Surg Gynecol Obstet. 1966;122(5):1039-45.
8. Leksell L. Echoencephalography I. Detection of intracranial complications following head injury. Acta Chir Scandinav. 1955;110:301.
9. Edler I, Hertz CH. The use of ultrasonic reflectoscope for the continuous recording of movements of heart walls. Kungl Fysiogr Sällsk i Lund firhandl. 1954;24:5.
10. Satomura S. Ultrasonic Doppler Method for the Inspection of Cardiac Functions. J Acoust Soc Am. 1957;29(11):1181-5. DOI:10.1121/1.1908737
11. Kasai C, Namekawa K, Koyano A, Omoto R. Real-Time Two-Dimensional Blood Flow Imaging Using an Autocorrelation Technique. IEEE Transactions on Sonics and Ultrasonics. 1985;32(3):458-64. DOI:10.1109/T-SU.1985.31615
12. Gramiak R, Shah P. Echocardiography of the aortic root. Invest Radiol. 1968;3:356-66.
13. Enhancing the Role of Ultrasound with Contrast Agents. Ed. R Lencioni. Springer, 2006; p. 262.
14. Feinstein SB, Shah PM, Bing RJ, et al. Microbubble dynamics visualized in the intact capillary circulation. J Am Coll Cardiol. 1984;4(3):595-600. DOI:10.1016/s0735-1097(84)80107-2
15. Schürmann R, Schlief R. Saccharide-based contrast agents. Characteristics and diagnostic potential. Radiol Med. 1994;87(5 Suppl. 1):15-23.
16. Kalantarinia K, Okusa MD. Ultrasound contrast agents in the study of kidney function in health and disease. Drug Discov Today Dis Mech. 2007;4(3):153-8. DOI:10.1016/j.ddmec.2007.10.006
17. Qin S, Caskey CF, Ferrara KW. Ultrasound contrast microbubbles in imaging and therapy: physical principles and engineering. Phys Med Biol. 2009;54(6):R27-57.
DOI:10.1088/0031-9155/54/6/R01
18. Wei K, Mulvagh SL, Carson L, et al. The safety of deFinity and Optison for ultrasound image enhancement: a retrospective analysis of 78,383 administered contrast doses. J Am Soc Echocardiogr. 2008;21(11):1202-6. DOI:10.1016/j.echo.2008.07.019
19. Lindner JR. Contrast echocardiography: current status and future directions. Heart. 2021;107(1):18-24. DOI:10.1136/heartjnl-2020-316662
20. Porter TR, Mulvagh SL, Abdelmoneim SS, et al. Clinical Applications of Ultrasonic Enhancing Agents in Echocardiography: 2018 American Society of Echocardiography Guidelines Update. J Am Soc Echocardiogr. 2018;31(3):241-74. DOI:10.1016/j.echo.2017.11.013
21. Levey AS, Cattran D, Friedman A, et al. Proteinuria as a surrogate outcome in CKD: report of a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration. Am J Kidney Dis. 2009;54(2):205-26. DOI:10.1053/j.ajkd.2009.04.029
22. Jeong S, Park SB, Kim SH, et al. Clinical significance of contrast-enhanced ultrasound in chronic kidney disease: a pilot study. J Ultrasound. 2019;22(4):453-60.
DOI:10.1007/s40477-019-00409-x
23. Wang L, Xia P, Lv K, et al. Assessment of renal tissue elasticity by acoustic radiation force impulse quantification with histopathological correlation: preliminary experience in chronic kidney disease. Eur Radiol. 2014;24(7):1694-9. DOI:10.1007/s00330-014-3162-5
24. Claudon M, Dietrich CF, Choi BI, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver – update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultraschall Med. 2013;34(1):11-29. DOI:10.1055/s-0032-1325499
25. Erlichman DB, Weiss A, Koenigsberg M, Stein MW. Contrast enhanced ultrasound: A review of radiology applications. Clin Imaging. 2020;60(2):209-15. DOI:10.1016/j.clinimag.2019.12.013
26. Bansal M, Kasliwal RR. Echocardiography for left atrial appendage structure and function. Indian Heart J. 2012;64(5):469-75. DOI:10.1016/j.ihj.2012.07.020
27. Eriksson MJ, Sonnenberg B, Woo A, et al. Long-term outcome in patients with apical hypertrophic cardiomyopathy. J Am Coll Cardiol. 2002;39(4):638-45.
DOI:10.1016/s0735-1097(01)01778-8
28. Hoffmann R, Barletta G, von Bardeleben S, et al. Analysis of left ventricular volumes and function: a multicenter comparison of cardiac magnetic resonance imaging, cine ventriculography, and unenhanced and contrast-enhanced two-dimensional and three-dimensional echocardiography. J Am Soc Echocardiogr. 2014;27(3):292-301. DOI:10.1016/j.echo.2013.12.005
29. Kurt M, Shaikh KA, Peterson L, et al. Impact of contrast echocardiography on evaluation of ventricular function and clinical management in a large prospective cohort. J Am Coll Cardiol. 2009;53(9):802-10. DOI:10.1016/j.jacc.2009.01.005
30. Ogbogu PU, Rosing DR, Horne MK 3rd. Cardiovascular manifestations of hypereosinophilic syndromes. Immunol Allergy Clin North Am. 2007;27(3):457-75. DOI:10.1016/j.iac.2007.07.001
31. Vos HJ, Voorneveld JD, Groot Jebbink E, et al. Contrast-Enhanced High-Frame-Rate Ultrasound Imaging of Flow Patterns in Cardiac Chambers and Deep Vessels. Ultrasound Med Biol. 2020;46(11):2875-90. DOI:10.1016/j.ultrasmedbio.2020.07.022
32. Frinking P, Segers T, Luan Y, Tranquart F. Three Decades of Ultrasound Contrast Agents: A Review of the Past, Present and Future Improvements. Ultrasound Med Biol. 2020;46(4):892-908. DOI:10.1016/j.ultrasmedbio.2019.12.008
33. Nittayacharn P, Yuan HX, Hernandez C, et al. Enhancing Tumor Drug Distribution With Ultrasound-Triggered Nanobubbles. J Pharm Sci. 2019;108(9):3091-8. DOI:10.1016/j.xphs.2019.05.004
34. Chong WK, Papadopoulou V, Dayton PA. Imaging with ultrasound contrast agents: current status and future. Abdom Radiol (NY). 2018;43(4):762-72.
DOI:10.1007/s00261-018-1516-1
________________________________________________
2. Marinesco N, Trillat JJ. Action des ultrasons sur les plaques photographique. C R Acad Sci. 1933;196:858-60.
3. Marinesco N. Propriétés piézo-chimiques, physiques et biophysiques des ultrasons. I et II. Actualités scientifiques et industrielles. 522 & 523. Paris: Hermann, 1937.
4. Dussik K. Über die Möglichkeit hochfrequente mechanische Schwingungen als diagnostiches Hilfsmittel zi verwenden. Z Neur. 1942;174:153.
5. Dussik K. Ultraschallanwendung in der Diagnostik und Therapie des Erkrankungen des zentralen Nervensus-sytems. Ultrasch in der Med. 1949;1:283.
6. Howry DH, Bliss WR. Ultrasonic visualization of soft tissue structures of the body. J Lab Clin Med. 1952;40:579-92.
7. Strandness DE Jr., McCutcheon EP, Rushmer RF. Application of a transcutaneous Doppler flowmeter in evaluation of occlusive arterial disease. Surg Gynecol Obstet. 1966;122(5):1039-45.
8. Leksell L. Echoencephalography I. Detection of intracranial complications following head injury. Acta Chir Scandinav. 1955;110:301.
9. Edler I, Hertz CH. The use of ultrasonic reflectoscope for the continuous recording of movements of heart walls. Kungl Fysiogr Sällsk i Lund firhandl. 1954;24:5.
10. Satomura S. Ultrasonic Doppler Method for the Inspection of Cardiac Functions. J Acoust Soc Am. 1957;29(11):1181-5. DOI:10.1121/1.1908737
11. Kasai C, Namekawa K, Koyano A, Omoto R. Real-Time Two-Dimensional Blood Flow Imaging Using an Autocorrelation Technique. IEEE Transactions on Sonics and Ultrasonics. 1985;32(3):458-64. DOI:10.1109/T-SU.1985.31615
12. Gramiak R, Shah P. Echocardiography of the aortic root. Invest Radiol. 1968;3:356-66.
13. Enhancing the Role of Ultrasound with Contrast Agents. Ed. R Lencioni. Springer, 2006; p. 262.
14. Feinstein SB, Shah PM, Bing RJ, et al. Microbubble dynamics visualized in the intact capillary circulation. J Am Coll Cardiol. 1984;4(3):595-600. DOI:10.1016/s0735-1097(84)80107-2
15. Schürmann R, Schlief R. Saccharide-based contrast agents. Characteristics and diagnostic potential. Radiol Med. 1994;87(5 Suppl. 1):15-23.
16. Kalantarinia K, Okusa MD. Ultrasound contrast agents in the study of kidney function in health and disease. Drug Discov Today Dis Mech. 2007;4(3):153-8. DOI:10.1016/j.ddmec.2007.10.006
17. Qin S, Caskey CF, Ferrara KW. Ultrasound contrast microbubbles in imaging and therapy: physical principles and engineering. Phys Med Biol. 2009;54(6):R27-57.
DOI:10.1088/0031-9155/54/6/R01
18. Wei K, Mulvagh SL, Carson L, et al. The safety of deFinity and Optison for ultrasound image enhancement: a retrospective analysis of 78,383 administered contrast doses. J Am Soc Echocardiogr. 2008;21(11):1202-6. DOI:10.1016/j.echo.2008.07.019
19. Lindner JR. Contrast echocardiography: current status and future directions. Heart. 2021;107(1):18-24. DOI:10.1136/heartjnl-2020-316662
20. Porter TR, Mulvagh SL, Abdelmoneim SS, et al. Clinical Applications of Ultrasonic Enhancing Agents in Echocardiography: 2018 American Society of Echocardiography Guidelines Update. J Am Soc Echocardiogr. 2018;31(3):241-74. DOI:10.1016/j.echo.2017.11.013
21. Levey AS, Cattran D, Friedman A, et al. Proteinuria as a surrogate outcome in CKD: report of a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration. Am J Kidney Dis. 2009;54(2):205-26. DOI:10.1053/j.ajkd.2009.04.029
22. Jeong S, Park SB, Kim SH, et al. Clinical significance of contrast-enhanced ultrasound in chronic kidney disease: a pilot study. J Ultrasound. 2019;22(4):453-60.
DOI:10.1007/s40477-019-00409-x
23. Wang L, Xia P, Lv K, et al. Assessment of renal tissue elasticity by acoustic radiation force impulse quantification with histopathological correlation: preliminary experience in chronic kidney disease. Eur Radiol. 2014;24(7):1694-9. DOI:10.1007/s00330-014-3162-5
24. Claudon M, Dietrich CF, Choi BI, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver – update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultraschall Med. 2013;34(1):11-29. DOI:10.1055/s-0032-1325499
25. Erlichman DB, Weiss A, Koenigsberg M, Stein MW. Contrast enhanced ultrasound: A review of radiology applications. Clin Imaging. 2020;60(2):209-15. DOI:10.1016/j.clinimag.2019.12.013
26. Bansal M, Kasliwal RR. Echocardiography for left atrial appendage structure and function. Indian Heart J. 2012;64(5):469-75. DOI:10.1016/j.ihj.2012.07.020
27. Eriksson MJ, Sonnenberg B, Woo A, et al. Long-term outcome in patients with apical hypertrophic cardiomyopathy. J Am Coll Cardiol. 2002;39(4):638-45.
DOI:10.1016/s0735-1097(01)01778-8
28. Hoffmann R, Barletta G, von Bardeleben S, et al. Analysis of left ventricular volumes and function: a multicenter comparison of cardiac magnetic resonance imaging, cine ventriculography, and unenhanced and contrast-enhanced two-dimensional and three-dimensional echocardiography. J Am Soc Echocardiogr. 2014;27(3):292-301. DOI:10.1016/j.echo.2013.12.005
29. Kurt M, Shaikh KA, Peterson L, et al. Impact of contrast echocardiography on evaluation of ventricular function and clinical management in a large prospective cohort. J Am Coll Cardiol. 2009;53(9):802-10. DOI:10.1016/j.jacc.2009.01.005
30. Ogbogu PU, Rosing DR, Horne MK 3rd. Cardiovascular manifestations of hypereosinophilic syndromes. Immunol Allergy Clin North Am. 2007;27(3):457-75. DOI:10.1016/j.iac.2007.07.001
31. Vos HJ, Voorneveld JD, Groot Jebbink E, et al. Contrast-Enhanced High-Frame-Rate Ultrasound Imaging of Flow Patterns in Cardiac Chambers and Deep Vessels. Ultrasound Med Biol. 2020;46(11):2875-90. DOI:10.1016/j.ultrasmedbio.2020.07.022
32. Frinking P, Segers T, Luan Y, Tranquart F. Three Decades of Ultrasound Contrast Agents: A Review of the Past, Present and Future Improvements. Ultrasound Med Biol. 2020;46(4):892-908. DOI:10.1016/j.ultrasmedbio.2019.12.008
33. Nittayacharn P, Yuan HX, Hernandez C, et al. Enhancing Tumor Drug Distribution With Ultrasound-Triggered Nanobubbles. J Pharm Sci. 2019;108(9):3091-8. DOI:10.1016/j.xphs.2019.05.004
34. Chong WK, Papadopoulou V, Dayton PA. Imaging with ultrasound contrast agents: current status and future. Abdom Radiol (NY). 2018;43(4):762-72.
DOI:10.1007/s00261-018-1516-1
Авторы
О.Ю. Миронова*, М.А. Исайкина, Г.О. Исаев, М.В. Бердышева, В.В. Фомин
ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский Университет), Москва, Россия
*mironova_o_yu@staff.sechenov.ru
Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia
*mironova_o_yu@staff.sechenov.ru
ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский Университет), Москва, Россия
*mironova_o_yu@staff.sechenov.ru
________________________________________________
Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia
*mironova_o_yu@staff.sechenov.ru
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.